These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35565216)

  • 81. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.
    Gevaert O; Xu J; Hoang CD; Leung AN; Xu Y; Quon A; Rubin DL; Napel S; Plevritis SK
    Radiology; 2012 Aug; 264(2):387-96. PubMed ID: 22723499
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A novel miRNA-based classification model of risks and stages for clear cell renal cell carcinoma patients.
    Dessie EY; Tsai JJP; Chang JG; Ng KL
    BMC Bioinformatics; 2021 May; 22(Suppl 10):270. PubMed ID: 34058987
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma.
    Zhang X; Wang Z; Zeng Z; Shen N; Wang B; Zhang Y; Shen H; Lu W; Wei R; Ma W; Wang C
    Cancer Cell Int; 2021 Apr; 21(1):222. PubMed ID: 33865387
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Radiomics and Radiogenomics in Pelvic Oncology: Current Applications and Future Directions.
    O'Sullivan NJ; Kelly ME
    Curr Oncol; 2023 May; 30(5):4936-4945. PubMed ID: 37232830
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Combining molecular and imaging metrics in cancer: radiogenomics.
    Lo Gullo R; Daimiel I; Morris EA; Pinker K
    Insights Imaging; 2020 Jan; 11(1):1. PubMed ID: 31901171
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Protein Arginine Methyltransferases Refine the Classification of Clear Cell Renal Cell Carcinoma with Distinct Prognosis and Tumor Microenvironment Characteristics.
    Ye S; Tian X; Anwaier A; Wei S; Liu W; Su J; Zhu S; Dai B; Gu J; Qu Y; Xu W; Zhang H; Ye D
    Int J Biol Sci; 2023; 19(14):4552-4570. PubMed ID: 37781030
    [No Abstract]   [Full Text] [Related]  

  • 87. Radiomics in hepatocellular carcinoma: a quantitative review.
    Wakabayashi T; Ouhmich F; Gonzalez-Cabrera C; Felli E; Saviano A; Agnus V; Savadjiev P; Baumert TF; Pessaux P; Marescaux J; Gallix B
    Hepatol Int; 2019 Sep; 13(5):546-559. PubMed ID: 31473947
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Positron Emission Tomography/Computed Tomography with
    Hekman MCH; Rijpkema M; Aarntzen EH; Mulder SF; Langenhuijsen JF; Oosterwijk E; Boerman OC; Oyen WJG; Mulders PFA
    Eur Urol; 2018 Sep; 74(3):257-260. PubMed ID: 29730017
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Artificial intelligence radiogenomics for advancing precision and effectiveness in oncologic care (Review).
    Trivizakis E; Papadakis GZ; Souglakos I; Papanikolaou N; Koumakis L; Spandidos DA; Tsatsakis A; Karantanas AH; Marias K
    Int J Oncol; 2020 Jul; 57(1):43-53. PubMed ID: 32467997
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Radiogenomics: bridging imaging and genomics.
    Bodalal Z; Trebeschi S; Nguyen-Kim TDL; Schats W; Beets-Tan R
    Abdom Radiol (NY); 2019 Jun; 44(6):1960-1984. PubMed ID: 31049614
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Fuhrman nuclear grade prediction of clear cell renal cell carcinoma: influence of volume of interest delineation strategies on machine learning-based dynamic enhanced CT radiomics analysis.
    Luo S; Wei R; Lu S; Lai S; Wu J; Wu Z; Pang X; Wei X; Jiang X; Zhen X; Yang R
    Eur Radiol; 2022 Apr; 32(4):2340-2350. PubMed ID: 34636962
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Advances in Imaging-Based Biomarkers in Renal Cell Carcinoma: A Critical Analysis of the Current Literature.
    Posada Calderon L; Eismann L; Reese SW; Reznik E; Hakimi AA
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672304
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The Construction and Validation of a new Predictive Model for Overall Survival of Clear Cell Renal Cell Carcinoma Patients with Bone Metastasis Based on Machine Learning Algorithm.
    Le Y; Xu W; Guo W
    Technol Cancer Res Treat; 2023; 22():15330338231165131. PubMed ID: 37078130
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Machine Learning and Radiogenomics: Lessons Learned and Future Directions.
    Kang J; Rancati T; Lee S; Oh JH; Kerns SL; Scott JG; Schwartz R; Kim S; Rosenstein BS
    Front Oncol; 2018; 8():228. PubMed ID: 29977864
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Radiogenomics: Contemporary Applications in the Management of Rectal Cancer.
    O'Sullivan NJ; Temperley HC; Horan MT; Corr A; Mehigan BJ; Larkin JO; McCormick PH; Kavanagh DO; Meaney JFM; Kelly ME
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136361
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Radiogenomic biomarkers for immunotherapy in glioblastoma: A systematic review of magnetic resonance imaging studies.
    Ghimire P; Kinnersley B; Karami G; Arumugam P; Houlston R; Ashkan K; Modat M; Booth TC
    Neurooncol Adv; 2024; 6(1):vdae055. PubMed ID: 38680991
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Molecular Profile of Important Genes for Radiogenomics in the Amazon Indigenous Population.
    de Lima MC; de Castro CC; Aguiar KEC; Monte N; Nunes GGDC; Costa ACAD; Rodrigues JCG; Guerreiro JF; Ribeiro-Dos-Santos Â; Assumpção PP; Burbano RMR; Fernandes MR; Dos Santos SEB; Dos Santos NPC
    J Pers Med; 2024 Apr; 14(5):. PubMed ID: 38793065
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Radiomics and Radiogenomics Toward Personalized Management of Clear Cell Renal Cell Carcinoma: The Importance of FOXM1.
    Greco F; Mallio CA
    Acad Radiol; 2024 Aug; ():. PubMed ID: 39097509
    [No Abstract]   [Full Text] [Related]  

  • 99. Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects.
    Ferro M; Musi G; Marchioni M; Maggi M; Veccia A; Del Giudice F; Barone B; Crocetto F; Lasorsa F; Antonelli A; Schips L; Autorino R; Busetto GM; Terracciano D; Lucarelli G; Tataru OS
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902045
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
    Gao J; Ye F; Han F; Jiang H; Zhang J
    Front Immunol; 2022; 13():956679. PubMed ID: 36177018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.